Danda Trouve Investment Management, Inc. Astrazeneca PLC Call Options Transaction History
Danda Trouve Investment Management, Inc.
- $54.1 Million
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...